Table 3.
Group | HR (95% CI) CHD* from Cox Proportional Hazards Regression | |||
---|---|---|---|---|
apoB and nonHDLc | ||||
Model 1** | Model 2** | Model 3** | Model 4** | |
Discordant High apoB | 1.77 (1.56, 2.00) | 1.67 (1.48, 1.89) | 1.22 (1.07, 1.39) | 1.14 (1.00, 1.30)† |
Concordant | ref. | ref. | ref. | ref. |
Discordant Low apoB | 0.87 (0.74, 1.01) | 0.88 (0.75, 1.03) | 0.97 (0.83, 1.14) | 0.93 (0.79, 1.10) |
Group | LDLp and nonHDLc | |||
Model 1** | Model 2** | Model 3** | Model 4** | |
Discordant High LDLp | 1.70 (1.50, 1.92) | 1.57 (1.39, 1.78) | 1.13 (0.99, 1.29) | 1.06 (0.93, 1.21) |
Concordant | ref. | ref. | ref. | ref. |
Discordant Low LDLp | 0.93 (0.80, 1.08) | 0.93 (0.80, 1.09) | 1.04 (0.89, 1.22) | 0.98 (0.83, 1.15) |
Abbreviations: CI = confidence interval; HR = hazard ratio.
Model 1 = randomization age-adjusted; Model 2 = Model 1 + randomized treatment assignment, hormone use, postmenopausal status, smoking (baseline history or not), and history of baseline hypertension; Model 3 = Model 2 + metabolic syndrome, diabetes mellitus (pre-randomization), body mass index, HDLc, triglycerides, high-sensitivity C-reactive protein (hsCRP), and parental history of premature myocardial infarction; Model 4 = Model 3 + baseline concentration of nonHDLc.
For apoB: P<0.001 for Models 1 and 2, P=0.002 for Model 3, P=0.012 for Model 4; for LDLp: P<0.001 for Models 1 and 2, P=0.23 for Model 3, P= 0.29 for Model 4.
P=0=0.046.